85 related articles for article (PubMed ID: 3118089)
1. [The mechanism of the development of pulmonary hypertension induced by monocrotaline in rats].
Kataoka R; Tobise K
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 May; 25(5):563-73. PubMed ID: 3118089
[No Abstract] [Full Text] [Related]
2. [Morphological study of monocrotaline-induced pulmonary hypertension in rats].
Nakashima M
Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Mar; 21(3):227-39. PubMed ID: 6415328
[No Abstract] [Full Text] [Related]
3. [Reduction of the development of monocrotaline-induced pulmonary hypertension in rats by artificial unilateral pneumothorax].
Sugita T; Sawada A; Kuriyama T; Yamagishi F; Kohchi F; Naitoh T; Kakusaka I; Okada O; Watanabe S; Ogata T
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1328-36. PubMed ID: 3937926
[No Abstract] [Full Text] [Related]
4. Changes in main pulmonary artery of rats with monocrotaline-induced pulmonary hypertension.
Guzowski DE; Salgado ED
Arch Pathol Lab Med; 1987 Aug; 111(8):741-5. PubMed ID: 3115224
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiological study on monocrotaline-induced pulmonary hypertension in rats (author's transl].
Kido M
Fukuoka Igaku Zasshi; 1981 Mar; 72(3):117-30. PubMed ID: 6790398
[No Abstract] [Full Text] [Related]
6. [Monocrotaline-induced pulmonary hypertension with special reference to the influence of dose, age, and sex].
Sawada A; Kuriyama T; Sugita T; Watanabe S
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 May; 23(5):578-83. PubMed ID: 3932735
[No Abstract] [Full Text] [Related]
7. [Mast cell hyperplasia in monocrotaline-induced pulmonary changes in rats].
Kuriyama T; Sawada A; Sugita T; Watanabe S; Shen SY; Hiroshima K; Hayashi Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Aug; 23(8):865-72. PubMed ID: 3935842
[No Abstract] [Full Text] [Related]
8. [Pulmonary circulatory disturbance due to pulmonary peripheral lesions--etiology of experimental pulmonary hypertension and cor pulmonale].
Watanabe S
Kokyu To Junkan; 1981 May; 29(5):481-5. PubMed ID: 6797009
[No Abstract] [Full Text] [Related]
9. Echocardiographic detection of pulmonary hypertension in anesthetized rats.
Cottrill CM; Johnson GL; Gillespie MN
Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):189-96. PubMed ID: 2969131
[TBL] [Abstract][Full Text] [Related]
10. Ca2(+)-induced contraction and hyperreactivity of pulmonary arterial smooth muscle in monocrotaline-treated rats.
Takenaka T; Ogawa Y; Tobise K
Jpn Circ J; 1990 May; 54(5):515-23. PubMed ID: 2122039
[TBL] [Abstract][Full Text] [Related]
11. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
Orlinska U; Olson JW; Gillespie MN
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
[TBL] [Abstract][Full Text] [Related]
12. Experimental study on monocrotaline induced pulmonary hypertensive rats. (1) Effect of long-term injection of immunosuppressant.
Tanabe T; Furuya H; Kanemoto N; Goto Y; Hata J
Tokai J Exp Clin Med; 1981 Jan; 6(1):41-8. PubMed ID: 6789505
[TBL] [Abstract][Full Text] [Related]
13. Altered artery mechanics and structure in monocrotaline pulmonary hypertension.
Langleben D; Szarek JL; Coflesky JT; Jones RC; Reid LM; Evans JN
J Appl Physiol (1985); 1988 Nov; 65(5):2326-31. PubMed ID: 3145283
[TBL] [Abstract][Full Text] [Related]
14. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs.
Hilliker KS; Bell TG; Roth RA
Thromb Haemost; 1983 Dec; 50(4):844-7. PubMed ID: 6665765
[TBL] [Abstract][Full Text] [Related]
15. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study.
Todorovich-Hunter L; Johnson DJ; Ranger P; Keeley FW; Rabinovitch M
Lab Invest; 1988 Feb; 58(2):184-95. PubMed ID: 3123799
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
Kay JM; Keane PM; Suyama KL; Gauthier D
Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
[TBL] [Abstract][Full Text] [Related]
17. [Experimental pulmonary hypertension--with special reference to physiopathology and etiology of pulmonary hypertension caused by monocrotaline].
Watanabe S
Kokyu To Junkan; 1979 Jan; 27(1):4-11. PubMed ID: 482744
[No Abstract] [Full Text] [Related]
18. Primary pulmonary hypertension, a review.
Widimský J
Cor Vasa; 1982; 24(5):309-17. PubMed ID: 6816507
[No Abstract] [Full Text] [Related]
19. All-trans retinoic acid in pulmonary vascular structural remodeling in rats with pulmonary hypertension induced by monocrotaline.
Qin Y; Zhou A; Ben X; Shen J; Liang Y; Li F
Chin Med J (Engl); 2001 May; 114(5):462-5. PubMed ID: 11780404
[TBL] [Abstract][Full Text] [Related]
20. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
